C07K2317/92 - page 40 - CPC Classification Index

#11701

20120087858

2012-04-12

Dual variable domain immunoglobulins and uses thereof

#11702

20120083015

2012-04-05

Antibodies against human tweak and uses thereof

#11703

20120082681

2012-04-05

Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders

#11704

20120082680

2012-04-05

ANTAGONISTS OF PCSK9

#11705

20120082679

2012-04-05

Antagonists of PCSK9

#11706

20120082670

2012-04-05

CD33 binding agents

#11707

20120082667

2012-04-05

Antibodies that specifically bind to A beta oligomers and use thereof

#11708

20120082666

2012-04-05

ANTIBODY COMPOSITIONS AND METHODS OF USE

#11709

20120082664

2012-04-05

OPTIMIZED ANTIBODIES THAT TARGET CD19

#11710

20120082663

2012-04-05

ANTI-CMET ANTAGONISTS

#11711

20120082662

2012-04-05

ANTI-CMET ANTAGONISTS

#11712

20120078028

2012-03-29

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

#11713

20120077964

2012-03-29

ANTAGONISTS OF PCSK9

#11714

20120077731

2012-03-29

Anti-IL-6R polypeptides and pharmaceutical compositions thereof

#11715

20120076803

2012-03-29

ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF

#11716

20120076802

2012-03-29

Human cytomegalovirus neutralising antibodies and use thereof

#11717

20120076799

2012-03-29

ANTAGONISTS OF PCSK9

#11718

20120076790

2012-03-29

Antibodies capable of blocking the interaction between CD48 and a CD48 receptor

#11719

20120076782

2012-03-29

Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i

#11720

20120076780

2012-03-29

Recombinant fusion protein and polynucleotide construct for immunotoxin production

#11721

20120071634

2012-03-22

Antibody Constant Region Variant

#11722

20120070448

2012-03-22

Antibody to human IL-3 receptor alpha chain

#11723

20120070446

2012-03-22

RSV specific binding molecule

#11724

20120070440

2012-03-22

Therapeutic use of anti-CS1 antibodies

#11725

20120070428

2012-03-22

TREATMENT OF VASCULARIZED PIGMENT EPITHELIAL DETACHMENT WITH ANTI-VEGF THERAPY

#11726

20120066777

2012-03-15

Test agent for visceral obesity and use thereof

#11727

20120065379

2012-03-15

Antibody constant region variant

#11728

20120064600

2012-03-15

Anti-5T4 antibodies and uses thereof

#11729

20120064547

2012-03-15

Diagnostic antibody assay

#11730

20120064097

2012-03-15

Enhanced Binding of Pro-Inflammatory Cytokines by Polysaccharide-Antibody Conjugates

#11731

20120064083

2012-03-15

Therapeutic use of anti-CS1 antibodies

#11732

20120064077

2012-03-15

Stable and soluble antibodies inhibiting TNFα

#11733

20120064069

2012-03-15

Therapeutic use of anti-CS1 antibodies

#11734

20120064068

2012-03-15

Therapeutic use of anti-CS1 antibodies

#11735

20120064067

2012-03-15

Therapeutic use of anti-CS1 antibodies

#11736

20120064066

2012-03-15

Monoclonal Antibodies to Hepatocyte Growth Factor

#11737

20120064001

2012-03-15

Anti-VEGF antibody compositions and methods

#11738

20120064000

2012-03-15

Human monoclonal antibodies against hendra and nipah viruses

#11739

20120063999

2012-03-15

PSCA: prostate stem cell antigen and uses thereof

#11740

20120063998

2012-03-15

Method for treating psoriatic arthritis by administering an anti-IL-12 antibody

#11741

20120058906

2012-03-08

Combinatorial antibody libraries and uses thereof

#11742

20120058128

2012-03-08

ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES

#11743

20120058126

2012-03-08

Anti-VEGFR-3 antibody compositions

#11744

20120058122

2012-03-08

Antibodies directed to HER-3 and uses thereof

#11745

20120058118

2012-03-08

A-beta binding polypeptides

#11746

20120058116

2012-03-08

FGFR1C ANTIBODY COMBINATIONS

#11747

20120052569

2012-03-01

Tag peptide having a protease recognition sequence and use thereof

#11748

20120052566

2012-03-01

Anti-VEGF-C antibodies and methods using same

#11749

20120052074

2012-03-01

Human monoclonal antibodies to activin receptor-like kinase-1

#11750

20120052073

2012-03-01

Antibodies Directed to Angiopoietin-2 And Uses Thereof

#11751

20120052072

2012-03-01

High affinity human antibodies to human IL-4 receptor

#11752

20120052070

2012-03-01

COMPOSITIONS AND METHODS OF USE FOR BINDING MOLECULES TO DICKKOPF-1 OR DICKKOPF-4 OR BOTH

#11753

20120052060

2012-03-01

Methods of treatment using human antibody molecules for IL-13

#11754

20120052007

2012-03-01

PERIPHERAL BLOOD SPARC BINDING ANTIBODIES AND USES THEREOF

#11755

20120045453

2012-02-23

Anti-IL-6 antibodies, compositions, methods and uses

#11756

20120045440

2012-02-23

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

#11757

20120045438

2012-02-23

Engineered anti-IL-13 antibodies, compositions, methods and uses

#11758

20120045437

2012-02-23

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

#11759

20120045436

2012-02-23

Humanized anti-CD70 binding agents and uses thereof

#11760

20120039915

2012-02-16

Glioblastoma multiforme-reactive antibodies and methods of use thereof

#11761

20120039910

2012-02-16

Use of IL-1beta compounds

#11762

20120039906

2012-02-16

PD-1 antibodies and PD-L1 antibodies and uses thereof

#11763

20120039899

2012-02-16

Anti-hemagglutinin antibody compositions and methods of use thereof

#11764

20120039898

2012-02-16

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

#11765

20120039879

2012-02-16

Streptavidin having low immunogenicity and use thereof

#11766

20120039878

2012-02-16

Anti-amyloid antibodies

#11767

20120039874

2012-02-16

HUMAN MONOCLONAL ANTIBODY AGAINST A COSTIMULATORY SIGNAL TRANSDUCTION MOLECULE AILIM AND PHARMACEUTICAL USE THEREOF

#11768

20120039873

2012-02-16

Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins

#11769

20120039807

2012-02-16

Anti-tenascin-C A2 antibodies and methods of use

#11770

20120034656

2012-02-09

Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17

#11771

20120034631

2012-02-09

ANTI-LYSOPHOSPHOLIPID ANTIBODY DESIGN USING ANTIBODY STRUCTURES

#11772

20120034237

2012-02-09

Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof

#11773

20120034232

2012-02-09

TLR3 binding agents

#11774

20120034231

2012-02-09

Therapeutic antibodies binding IL12Rβ1

#11775

20120034212

2012-02-09

Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases

#11776

20120034166

2012-02-09

Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

#11777

20120034160

2012-02-09

Dual variable domain immunoglobulins and uses thereof

#11778

20120033440

2012-02-09

Expandable liquid volume in an LED bulb

#11779

20120029172

2012-02-02

Humanized GM-CSF antibodies

#11780

20120028301

2012-02-02

SOMATIC HYPERMUTATION SYSTEMS

#11781

20120027778

2012-02-02

Frizzled-binding agents and their use in screening for WNT inhibitors

#11782

20120027774

2012-02-02

Metalloproteinase 9 binding proteins

#11783

20120027773

2012-02-02

Anti-RON antibodies

#11784

20120027765

2012-02-02

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#11785

20120027722

2012-02-02

HEPATITIS C VIRUS COMBINATION THERAPY

#11786

20120027686

2012-02-02

HK1-BINDING PROTEINS

#11787

20120023600

2012-01-26

Compositions and methods of use for antibodies of dickkopf-1

#11788

20120022237

2012-01-26

Antibody to SOST peptides

#11789

20120022236

2012-01-26

Recombinant anti-VLA4 antibody molecules

#11790

20120021512

2012-01-26

Interleukin-1 Alpha Antibodies and Methods of Use

#11791

20120020988

2012-01-26

Antibodies specifically binding to human TSLPR and methods of use

#11792

20120020986

2012-01-26

Antibodies to the PcrV antigen of

#11793

20120020981

2012-01-26

Anti-IL6/IL-6R antibodies

#11794

20120020980

2012-01-26

High affinity human antibodies to human cytomegalovirus (CMV) gB protein

#11795

20120020976

2012-01-26

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

#11796

20120020975

2012-01-26

Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

#11797

20120020972

2012-01-26

Antibodies relating to PIVKA-II and uses thereof

#11798

20120020971

2012-01-26

Antibodies useful in passive influenza immunization

#11799

20120020968

2012-01-26

Chimeric RGMa polypeptides

#11800

20120020961

2012-01-26

Methods and compositions for liver cancer therapy

#11801

20120016106

2012-01-19

Polynucleotides encoding antagonist antibodies against GDF-8

#11802

20120015435

2012-01-19

Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody

#11803

20120015433

2012-01-19

Interleukin-1 alpha antibodies and methods of use

#11804

20120015384

2012-01-19

Interleukin-1α antibodies and methods of use

#11805

20120014975

2012-01-19

MODIFIED SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND USES THEREOF

#11806

20120014971

2012-01-19

Interleukin-1 alpha antibodies and methods of use

#11807

20120014967

2012-01-19

Method of treating inflammatory eye disease with IL-1β binding antibodies

#11808

20120014960

2012-01-19

Composition comprising antibodies to LINGO or fragments thereof

#11809

20120014958

2012-01-19

Stable and soluble antibodies inhibiting VEGF

#11810

20120014957

2012-01-19

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

#11811

20120014955

2012-01-19

Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity

#11812

20120014951

2012-01-19

Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9

#11813

20120014950

2012-01-19

Antibodies That Specifically Bind to DR3

#11814

20120014946

2012-01-19

PREVENTION AND TREATMENT OF PAIN USING MONOCLONAL ANTIBODIES AND ANTIBODY FRAGMENTS TO LYSOPHOSPHATIDIC ACID

#11815

20120014945

2012-01-19

Anti-dengue virus antibodies

#11816

20120014944

2012-01-19

Prevention and treatment of pain using antibodies to lysophosphatidic acid

#11817

20120014941

2012-01-19

Anti-BV8 antibodies and uses thereof

#11818

20120010388

2012-01-12

LeY SPECIFIC BIOTHERAPEUTIC

#11819

20120010387

2012-01-12

Antibody variants composition

#11820

20120009622

2012-01-12

Alpha5-beta1 antibodies and their uses

#11821

20120009207

2012-01-12

Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells

#11822

20120009200

2012-01-12

Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment

#11823

20120009195

2012-01-12

Antibody neutralizers of human granulocyte macrophage colony stimulating factor

#11824

20120009192

2012-01-12

Methods of using anti-CGRP antagonist antibodies

#11825

20120009191

2012-01-12

METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST

#11826

20120009188

2012-01-12

Optimized FC variants

#11827

20120009184

2012-01-12

Methods of treating a disease with anti-C5 alpha antibodies

#11828

20120009181

2012-01-12

Folate receptor 1 antibodies and immunoconjugates and uses thereof

#11829

20120009180

2012-01-12

Anti-Aβ oligomer humanized antibody

#11830

20120009179

2012-01-12

Anti-Aβ oligomer humanized antibody

#11831

20120006716

2012-01-12

Humanized anti-IL-6 antibodies

#11832

20120005767

2012-01-05

Antibodies to insulin-like growth factor I receptor

#11833

20120003697

2012-01-05

High affinity antibodies to human IL-6 receptor

#11834

20120003245

2012-01-05

Anti-cobra toxin antibody fragments and method of producing a VH library

#11835

20120003237

2012-01-05

Wise binding agents and epitopes

#11836

20120003235

2012-01-05

ANTI-LYMPHOTOXIN ANTIBODIES

#11837

20120003212

2012-01-05

Method for treating muscular dystrophy using antagonist antibodies against GDF-8

#11838

20120003211

2012-01-05

Immunoglobulins with reduced aggregation

#11839

20110319292

2011-12-29

METHODS FOR GENERATING ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES

#11840

20110318758

2011-12-29

Human monoclonal antibodies and methods for producing the same

#11841

20110318757

2011-12-29

Recombinant anti-MUC1 antibodies

#11842

20110318356

2011-12-29

Antibodies against tissue factor pathway inhibitor

#11843

20110318353

2011-12-29

Humanized IL-25 antibodies

#11844

20110318348

2011-12-29

INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)

#11845

20110318347

2011-12-29

Amino acid sequences directed against cellular receptors for viruses and bacteria

#11846

20110318341

2011-12-29

Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8

#11847

20110318339

2011-12-29

Anti-DLL4 antibodies and uses thereof

#11848

20110318337

2011-12-29

HUMANEERED ANTI-FACTOR B ANTIBODY

#11849

20110318301

2011-12-29

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

#11850

20110313230

2011-12-22

SPECIFIC BINDING PROTEINS AND USES THEREOF

#11851

20110313138

2011-12-22

Method for Producing Proteins

#11852

20110313137

2011-12-22

HER2 ANTIBODY COMPOSITIONS

#11853

20110312505

2011-12-22

Rapid isolation of monoclonal antibodies from animals

#11854

20110311553

2011-12-22

Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation

#11855

20110311552

2011-12-22

NOTCH1 receptor antibodies and methods of treatment

#11856

20110311550

2011-12-22

AGENTS FOR HCV TREATMENT

#11857

20110311549

2011-12-22

Methods for treating conditions associated with MASP-2 dependent complement activation

#11858

20110311517

2011-12-22

Antibodies and methods for treating estrogen receptor-associated diseases

#11859

20110311450

2011-12-22

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

#11860

20110311449

2011-12-22

Isolated antibodies which bind to CXC chemokine receptor 4

#11861

20110305714

2011-12-15

Identification and engineering of antibodies with variant FC regions and methods of using same

#11862

20110305711

2011-12-15

CGRP antibodies

#11863

20110305708

2011-12-15

Compositions and methods for the therapy and diagnosis of cytomegalovirus

#11864

20110305702

2011-12-15

Epitopes

#11865

20110305701

2011-12-15

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#11866

20110305696

2011-12-15

Anti-serum albumin binding variants

#11867

20110305687

2011-12-15

Anti-FGFR2 antibodies

#11868

20110301335

2011-12-08

ANTI-TNFR1 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS

#11869

20110301332

2011-12-08

ANTI-PAMP THERAPEUTIC ANTIBODIES

#11870

20110301331

2011-12-08

Stabilized polypeptide compositions

#11871

20110300158

2011-12-08

Anti-serum albumin binding variants

#11872

20110300157

2011-12-08

METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS

#11873

20110300156

2011-12-08

Human antibodies against tissue factor and methods of use thereof

#11874

20110300151

2011-12-08

Methods of treating moderate to severe hidradenitis suppurativa with anti-TNF-alpha antibodies

#11875

20110300146

2011-12-08

ANTI-CMET ANTAGONISTS

#11876

20110300139

2011-12-08

Generation, expression and characterization of the humanized K33N monoclonal antibody

#11877

20110300138

2011-12-08

Human anti TSHR antibodies

#11878

20110300077

2011-12-08

Human anti-alpha-synuclein antibodies

#11879

20110296546

2011-12-01

Human CTLA-4 antibodies and their uses

#11880

20110294145

2011-12-01

Reagents and methods for detecting a polymorphic protein

#11881

20110293632

2011-12-01

POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION

#11882

20110293630

2011-12-01

Antibodies to human GDF8

#11883

20110293623

2011-12-01

ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF

#11884

20110293622

2011-12-01

Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity

#11885

20110293618

2011-12-01

Anti-human CLCP1 antibody and use thereof

#11886

20110293614

2011-12-01

ISOFORM SPECIFIC ANTI-HER4 ANTIBODIES

#11887

20110293613

2011-12-01

Bispecific antibodies

#11888

20110293514

2011-12-01

Method of reducing pruritis using IL-31 monoclonal antibodies

#11889

20110293511

2011-12-01

SPECIFIC BINDING PROTEINS AND USES THEREOF

#11890

20110288278

2011-11-24

Diagnostic agent and therapeutic agent for pancreatic cancer

#11891

20110288276

2011-11-24

Crystals and structure of a human IgG Fc variant with enhanced FcRn binding

#11892

20110288005

2011-11-24

Alpha 1-antitrypsin compositions and methods of making and using same

#11893

20110287533

2011-11-24

Lowered affinity antibodies and uses therefor

#11894

20110287486

2011-11-24

Method for In Vitro Molecular Evolution of Protein Function

#11895

20110287485

2011-11-24

Methods of generating libraries and uses thereof

#11896

20110287028

2011-11-24

Methods of treatment using human anti-IL-23 antibodies

#11897

20110287023

2011-11-24

High affinity antibodies against HMGB1 and methods of use thereof

#11898

20110287009

2011-11-24

Production of heteromultimeric proteins

#11899

20110287005

2011-11-24

Monoclonal antibodies against amyloid beta protein and uses thereof

#11900

20110287002

2011-11-24

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

#11901

20110287000

2011-11-24

TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE

#11902

20110282036

2011-11-17

BSA-specific antibodies

#11903

20110281856

2011-11-17

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

#11904

20110281348

2011-11-17

AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAME

#11905

20110280883

2011-11-17

Fully human anti-epidermal growth factor receptor antibodies

#11906

20110280800

2011-11-17

IL-1 binding proteins

#11907

20110275790

2011-11-10

Antibodies to human IL-22

#11908

20110274704

2011-11-10

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#11909

20110274696

2011-11-10

Antibodies to CCR2

#11910

20110274687

2011-11-10

Methods of treating TSLP-related inflammatory disorders

#11911

20110274685

2011-11-10

Antibodies that bind human CD27 and uses thereof

#11912

20110274683

2011-11-10

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

#11913

20110271358

2011-11-03

Anti-PD-L1 antibodies and uses therefor

#11914

20110269186

2011-11-03

Antibodies against vascular endothelial growth factor receptor-1

#11915

20110268746

2011-11-03

Human cytomegalovirus neutralizing antibodies and use thereof

#11916

20110268740

2011-11-03

Fully human influenza M2 specific antibodies

#11917

20110268727

2011-11-03

ANTI-INTERFERON-ALPHA ANTIBODIES

#11918

20110268726

2011-11-03

Anti-CD38 human antibodies and uses thereof

#11919

20110268725

2011-11-03

Anti-NGF antibodies for the treatment of various disorders

#11920

20110263829

2011-10-27

CELL-PENETRATING, SEQUENCE-SPECIFIC AND NUCLEIC ACID-HYDROLYZING ANTIBODY, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#11921

20110263827

2011-10-27

Dual Variable Domain Immunnoglobulins and Uses Thereof

#11922

20110263825

2011-10-27

ANTI-CD20 MONOCLONAL ANTIBODIES

#11923

20110263436

2011-10-27

Recombinant antibodies against hepatitis C virus and methods of obtaining and using same

#11924

20110262460

2011-10-27

BLOOD-BRAIN BARRIER TARGETING ANTIBODIES

#11925

20110262452

2011-10-27

Anti-hepsin antibodies and methods using same

#11926

20110262448

2011-10-27

Human antibodies that bind mesothelin, and uses thereof

#11927

20110262447

2011-10-27

Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses

#11928

20110262446

2011-10-27

USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS

#11929

20110262445

2011-10-27

Anti-IL-12/IL-23 antibodies

#11930

20110262443

2011-10-27

Antibodies specific to IL-17A and IL-17F

#11931

20110262438

2011-10-27

Biological materials related to CXCR7

#11932

20110262435

2011-10-27

IL-13 BINDING AGENTS

#11933

20110262430

2011-10-27

NOVEL ANTIBODIES

#11934

20110262427

2011-10-27

AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM

#11935

20110262396

2011-10-27

COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERS

#11936

20110257371

2011-10-20

Methods of treating chronic pain

#11937

20110256635

2011-10-20

Soluble human ST-2 antibodies and assays

#11938

20110256587

2011-10-20

High affinity human antibodies to human nerve growth factor

#11939

20110256154

2011-10-20

Anti-ErbB3 antibodies

#11940

20110256153

2011-10-20

CD37-binding molecules and immunoconjugates thereof

#11941

20110256148

2011-10-20

Methods for treating hypercholesterolemia using antibodies to PCSK9

#11942

20110256146

2011-10-20

Neuropilin antagonists

#11943

20110256142

2011-10-20

NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER

#11944

20110256138

2011-10-20

Amyloid-beta binding proteins

#11945

20110256137

2011-10-20

Pharmaceutical composition comprising a bispecific antibody for EpCAM

#11946

20110256133

2011-10-20

Anti-polyubiquitin antibodies and methods of use

#11947

20110256132

2011-10-20

MYOSTATIN BINDING PROTEINS

#11948

20110256127

2011-10-20

Anti-LRP6 antibodies

#11949

20110256126

2011-10-20

IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof

#11950

20110256122

2011-10-20

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS

#11951

20110251373

2011-10-13

FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF

#11952

20110250681

2011-10-13

Fc Variants with Optimized Properties

#11953

20110250639

2011-10-13

Methods for producing soluble membrane-spanning proteins

#11954

20110250211

2011-10-13

Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins

#11955

20110250205

2011-10-13

Anti-sclerostin antibodies

#11956

20110250203

2011-10-13

ANTI-CD5 ANTIBODIES

#11957

20110250202

2011-10-13

Reagents, methods, and systems for detecting methicillin-resistant

#11958

20110250201

2011-10-13

Antagonists of IL-6 to raise albumin and/or lower CRP

#11959

20110250130

2011-10-13

TNF-α binding proteins

#11960

20110245473

2011-10-06

Anti-IL-6 Receptor Antibody

#11961

20110245100

2011-10-06

GENERATION OF ANTIBODIES TO AN EPITOPE OF INTEREST

#11962

20110244011

2011-10-06

Specific delivery of agrochemicals

#11963

20110243963

2011-10-06

Antibodies to LRP6

#11964

20110243962

2011-10-06

Therapeutic use of specific ligand in MSRV associated diseases

#11965

20110243955

2011-10-06

Antibody and uses thereof

#11966

20110243954

2011-10-06

PEPTIDES CAPABLE OF BINDING TO SERUM PROTEINS AND COMPOUNDS, CONSTRUCTS AND POLYPEPTIDES COMPRISING THE SAME

#11967

20110243952

2011-10-06

COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION

#11968

20110243948

2011-10-06

Monoclonal antibodies against ANGPTL3

#11969

20110243947

2011-10-06

Antibodies against CSF-1R

#11970

20110243945

2011-10-06

Anti-inflammatory agents

#11971

20110243932

2011-10-06

Anti-CD40 antibodies

#11972

20110243926

2011-10-06

Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases

#11973

20110243840

2011-10-06

Monoclonal antibodies against orthopoxviruses

#11974

20110237779

2011-09-29

CDR-repaired antibodies

#11975

20110236969

2011-09-29

METHODS OF GENERATING VARIANT PROTEINS WITH INCREASED HOST STRING CONTENT AND COMPOSITIONS THEREOF

#11976

20110236968

2011-09-29

Humanized antibodies against monocyte chemotactic proteins

#11977

20110236390

2011-09-29

IL-17A antibodies

#11978

20110236388

2011-09-29

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

#11979

20110236387

2011-09-29

Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereof

#11980

20110236378

2011-09-29

Non-human mammals for the production of chimeric antibodies

#11981

20110236377

2011-09-29

()

#11982

20110236375

2011-09-29

Antibody variants with enhanced complement activity

#11983

20110230646

2011-09-22

Hybrid antibodies

#11984

20110229489

2011-09-22

Anti-PCSK9 antibodies with pH dependent antigen binding

#11985

20110229463

2011-09-22

Methods using recombinant anti-epidermal growth factor receptor antibody compositions

#11986

20110229462

2011-09-22

Hepatocyte growth factor (HGF) binding proteins

#11987

20110229461

2011-09-22

PD-1 antibodies

#11988

20110229459

2011-09-22

Anti-NR10 antibody and use thereof

#11989

20110229406

2011-09-22

Material and methods for treating or preventing HER-3 associated diseases

#11990

20110224408

2011-09-15

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

#11991

20110223178

2011-09-15

Antibodies That Specifically Bind to Chemokine Beta-4

#11992

20110223176

2011-09-15

BASIGIN BINDING PROTEINS

#11993

20110223168

2011-09-15

LIGAND THAT HAS BINDING SPECIFICITY FOR IL-4 AND/OR IL-13

#11994

20110223165

2011-09-15

Humanized C-kit antibody

#11995

20110223163

2011-09-15

Monoclonal antibodies that react with the capsule of

#11996

20110223160

2011-09-15

Compositions and methods relating to glucagon receptor antibodies

#11997

20110223159

2011-09-15

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#11998

20110218333

2011-09-08

Internalizing ErbB2 antibodies

#11999

20110218329

2011-09-08

ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES

#12000

20110218328

2011-09-08

Chimeric, humanized, or human antibody 2A4